Health Care: Drugs

Atossa Genetics Inc (ATOS: NASDAQ)

$0.41 n/a | n/a%
07/20/17 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 0.41
52 Week High 4.35
52 Week Low 0.40
Avg. Daily Vol. (Mil) 0.29
Beta (3 year) 2.01
Share Related Items
Mkt Cap (Mil) 3.50
Shares Out (Mil) 8.53
Float (Mil) 5.65
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio n.a.
Financial Strength
Quick Ratio n.a.
Current Ratio n.a.
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 1.99K
Price/Book 1.45
Price/Cash Flow -0.30
Per Share Data
Earnings 0.00
Sales 0.00
Book Value 0.28
Cash Flow -1.56
Business Summary
Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
General Information
107 Spring Street
Seattle, WA 98104
Industry : Drugs
Sector: Health Care
Employees: 4
CEO: Steven C. Quay,M.D.
Short Interest
Current Month (Mil) 0.35
Previous Month (Mil) 0.30
Short Interest Ratio (Days) 1.80
Management Effectiveness
Return on Equity n.a.
Return on Assets 0.00
Return on Investments n.a.
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ATOS

Latest ATOS Headlines from TheStreet

More Financial News for ATOS

Press Releases for ATOS

See All Press Releases

Partner Headlines for ATOS

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter